Cardiovascular risk in axial spondyloarthritis—a systematic review

被引:0
|
作者
Rainer Hintenberger
Barbara Affenzeller
Valeriia Vladychuk
Herwig Pieringer
机构
[1] Department for Internal Medicine II,Department for Internal Medicine II
[2] Kepler University Hospital GmbH,undefined
[3] Johannes Kepler University Linz,undefined
[4] Kepler University Hospital GmbH,undefined
[5] Diakonissen Hospital Linz,undefined
[6] Linz,undefined
[7] Austria and Paracelsus Private Medical University Salzburg,undefined
来源
Clinical Rheumatology | 2023年 / 42卷
关键词
Atherosclerosis ; Axial spondyloarthritis; Heart disease; Hyperlipidemia; Vascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular manifestations are common in patients suffering axial spondyloarthritis and can result in substantial morbidity and disease burden. To give an overview of this important aspect of axial spondyloarthritis, we conducted a systematic literature search of all articles published between January 2000 and 25 May 2023 on cardiovascular manifestations. Using PubMed and SCOPUS, 123 out of 6792 articles were identified and included in this review. Non-radiographic axial spondyloarthritis seems to be underrepresented in studies; thus, more evidence for ankylosing spondylitis exists. All in all, we found some traditional risk factors that led to higher cardiovascular disease burden or major cardiovascular events. These specific risk factors seem to be more aggressive in patients with spondyloarthropathies and have a strong connection to high or long-standing disease activity. Since disease activity is a major driver of morbidity, diagnostic, therapeutic, and lifestyle interventions are crucial for better outcomes.
引用
收藏
页码:2621 / 2633
页数:12
相关论文
共 50 条
  • [21] Impact of treatments on fatigue in axial spondyloarthritis: a systematic review and meta-analysis
    Delcourt, Clementine
    Fakih, Olivier
    Prati, Clement
    Chouk, Mickael
    Wendling, Daniel
    Verhoeven, Frank
    RHEUMATOLOGY, 2024, : 1585 - 1597
  • [22] Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis
    Zhao, Sizheng Steven
    Robertson, Selina
    Reich, Tzvi
    Harrison, Nicolas L.
    Moots, Robert J.
    Goodson, Nicola J.
    RHEUMATOLOGY, 2020, 59 : 47 - 57
  • [23] Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review
    Roifman, Idan
    Beck, Paul L.
    Anderson, Todd J.
    Eisenberg, Mark J.
    Genest, Jacques
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (02) : 174 - 182
  • [24] Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis
    Ladehesa-Pineda, Maria Lourdes
    Arias de la Rosa, Ivan
    Lopez Medina, Clementina
    Castro-Villegas, Maria del Carmen
    Abalos-Aguilera, Maria del Carmen
    Ortega-Castro, Rafaela
    Gomez-Garcia, Ignacio
    Segui-Azpilcueta, Pedro
    Jimenez-Gomez, Yolanda
    Escudero-Contreras, Alejandro
    Lopez Pedrera, Chary
    Barbarroja, Nuria
    Collantes-Estevez, Eduardo
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [25] Diabetes in axial spondyloarthritis: a systematic review and meta-analysis of observational studies
    Gumber, Leher
    Samarasinghe, Harini
    Gladston, Praveen
    Moorthy, Arumugam
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (11) : 2381 - 2388
  • [26] Increase in axial spondyloarthritis diagnoses after the introduction of the ASAS criteria: a systematic review
    Maha Jamal
    Elke Theodora Antonia Maria van Delft
    Hannah den Braanker
    Tjallingius Martijn Kuijper
    Johanna Mieke Wilhelmina Hazes
    Deirisa Lopes Barreto
    Angelique Elisabeth Adriana Maria Weel
    Rheumatology International, 2023, 43 : 639 - 649
  • [27] Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis
    Oh Chan Kwon
    Min-Chan Park
    Arthritis Research & Therapy, 24
  • [28] Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
    Remuzgo-Martinez, Sara
    Rueda-Gotor, Javier
    Pulito-Cueto, Veronica
    Lopez-Mejias, Raquel
    Corrales, Alfonso
    Lera-Gomez, Leticia
    Perez-Fernandez, Raquel
    Portilla, Virginia
    Gonzalez-Mazon, Inigo
    Blanco, Ricardo
    Exposito, Rosa
    Mata, Cristina
    Llorca, Javier
    Hernandez-Hernandez, Vanesa
    Rodriguez-Lozano, Carlos
    Barbarroja, Nuria
    Ortega-Castro, Rafaela
    Vicente, Esther
    Fernandez-Carballido, Cristina
    Martinez-Vidal, Maria Paz
    Castro-Corredor, David
    Anino-Fernandez, Joaquin
    Peiteado, Diana
    Plasencia-Rodriguez, Chamaida
    Galindez-Agirregoikoa, Eva
    Garcia-Vivar, Maria Luz
    Vegas-Revenga, Nuria
    Urionaguena, Irati
    Gualillo, Oreste
    Quevedo-Abeledo, Juan Carlos
    Castaneda, Santos
    Ferraz-Amaro, Ivan
    Gonzalez-Gay, Miguel a.
    Genre, Fernanda
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments
    Sen, Rouhin
    Caplan, Liron
    Danila, Maria I.
    CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (02) : 95 - 107
  • [30] Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review
    Prada, Pablo Antonio Zurita
    Urrego Laurin, C. L.
    Guillen Astete, C. A.
    Kanaffo Caltelblanco, S.
    Navarro-Compan, V.
    CLINICAL RHEUMATOLOGY, 2021, 40 (05) : 1673 - 1686